LIVE EPISODE: Lessons from the 2024 Campaign Trail
HearSay
It’s been one of the most unconventional and consequential presidential elections in American history. Amid the confusion, division, and turbulence, we spotted some valuable insights and important takeaways. This special live episode of HearSay will help you make sense of the outcome so you can thrive in these post-election days, with lessons from both sides that you can leverage for your own work.
info_outline
Misinformation: How words shape perceptions
HearSay
In this episode of HearSay, Partners Michael Maslansky, Lee Hartley Carter, and Katie Cronen navigate the complex terrain of "bad facts" in messaging—a topic that is as timely as it is uncomfortable. In a landscape fraught with political controversies like Biden’s age and corporate scandals such as skyrocketing pharmaceutical prices, denial is simply not an option. Instead, our hosts unpack a transformative approach to confronting these tricky realities through the framework of the four Rs: Reject, Rebut, Reframe, and Replace. Tune in to sharpen your communication strategy and understand...
info_outline
Navigating Innovation: Selling the new in tech and beyond
HearSay
You’ve got a breakthrough innovation that is much better than what’s come before – why is it so hard to sell it? In this episode, CEO Michael Maslansky, Partner Keith Yazmir, and Senior Vice President Will Howard dissect the challenges of selling innovation whether you are selling enterprise technology, a new investment product, or plant-based meat. They discuss language tactics for conveying the benefits of innovation, address resistance to change, and offer solutions for navigating unrecognized problems. Through compelling examples and practical insights, the episode provides...
info_outline
The Price of Life: Shifting Perceptions of Pharmaceuticals
HearSay
In this episode, CEO Michael Maslansky, and Partners Lee Carter and Katie Cronen delve into the pharmaceutical industry's enduring reputation struggles, tracing their origins back to pre-pandemic times and exploring the transformative impact of COVID-19. Through insightful discussions and case studies, they’ll propose strategies for reshaping the industry's narrative, emphasizing the importance of recasting pharma as more than profit-driven entities and fostering consumer trust.
info_outline
The Language of the Candidates
HearSay
In this new episode of HearSay, Lee Carter and Ben Feller look at what the two presidential candidates are saying, what’s important about it – and what people should be listening for in the political months ahead. Now that President Biden and Former President Trump are officially set for a rematch, Lee and Ben will analyze their contrasting approaches to how they frame issues like the economy, threats to our democracy, and the issue looming above both of theme room—their age. Lee and Ben offer insights into the current political landscape and speculate on the future...
info_outline
The Real Cost of Corporate Speak
HearSay
Corporations think they know what they need to say but they can never say it when it comes to responsiveness, and empathy, but what is happening behind the scenes causing these crisis situations and what could they have said differently? In this episode of Hearsay, Michael Maslansky, Lee Carter, and Ben Feller explore different moments of crisis and share their insights on what the challenges of corporate speak are, what it cost corporations that do nothing, and the different solutions to manage a crisis.
info_outline
The LVIII Superbowl Ads
HearSay
Join Lee Carter, Keith Yazmir, and Will Howard in this special episode of HearSay as they delve into the world of Super Bowl ads. They'll debate which ads truly stood out, not just in terms of popularity but in their messaging impact. From breaking down language to assessing brand impact, this episode explores the ads that left a lasting impression on viewers during the biggest advertising night of the year.
info_outline
What Would You Have Said?: Boeing
HearSay
Once something goes wrong, it’s easy to criticize the message a company uses to respond. But it's much harder to figure out what they should have said instead. In this episode of Hearsay, Michael Maslansky, Lee Carter, and Will Howard dive into the wrongs, the rights, and how Boeing’s language will matter in the weeks and months ahead.
info_outline
Framing an Organization’s Mission with Theirworld
HearSay
What’s so hard about doing the right thing? In today’s environment, it’s often met with skepticism. So how do you take an organization with a noble cause: like educating the world’s youth and ending the global education crisis and get people to both care and act about it? In today’s show, we’ll talk through the process we go through in framing an organization’s mission and impact in a way that ensures you’re heard the right way.
info_outline
Language Moments of 2023
HearSay
What were those top Language Moments of 2023? As language experts, we’re always listening for those moments that change the way we view companies, politics, business… and each other. From Bidenomics to MAGAnomics, from rainbow capitalism to Barbenheimer, this year had more than its share of new language moments, and in this new episode of Hearsay, Michael Maslansky, Lee Carter, and guest Ben Feller talk through those big moments of the year that changed our view of the world around us.
info_outlineIn this episode, CEO Michael Maslansky, and Partners Lee Carter and Katie Cronen delve into the pharmaceutical industry's enduring reputation struggles, tracing their origins back to pre-pandemic times and exploring the transformative impact of COVID-19. Through insightful discussions and case studies, they’ll propose strategies for reshaping the industry's narrative, emphasizing the importance of recasting pharma as more than profit-driven entities and fostering consumer trust.